Kazia Therapeutics Recognized as "Drug Discovery Company of the Year" in 2026 BioTech Breakthrough Awards

The Quick Take
Recognition Highlights Kazia's Focus on Overcoming Treatment Resistance in Cancer SYDNEY, Nov. 5, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire General Business.
Related
Business
STAK Energy Signs Long-Term Agreement to Bring North Slope Natural Gas to Market
Agreement supports power development using previously stranded gas in northern Alaska ANCHORAGE, Alaska, Nov. 5, 2026 /PRNewswire/ -- STAK Energy Corporation…
Business
LA COMPAGNIE INTRODUCES YEAR-ROUND DIRECT BUSINESS CLASS SERVICE BETWEEN NEW YORK AND NICE
For the first time, the 100% Smart Business Class airline extends its New York–Nice service through the 2026–2027 winter season, offering the only direct…
Business
The RealReal Appoints Shar Dubey to Board of Directors
Former Match Group CEO Brings Deep Expertise in Technology, Digital Consumer Platforms and Scaling Global Businesses SAN FRANCISCO, Nov. 5, 2026 /PRNewswire/…
Local
NREF Announces Third Quarter 2026 Results, Provides Fourth Quarter 2026 Guidance
DALLAS, Nov. 5, 2026 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the…
